$2.17
+0.0000%Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.
Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.
Strong working capital position provides significant operational flexibility and financial cushion.
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.
FORA โข NASDAQ
| Forian Inc. Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
ASSETS | |||||||
CURRENT ASSETS | |||||||
12.9M | 4.6M | 6M | 2.8M | 18.7M | 665.5K | 494.0 | |
18.6M | 30.5M | 42.3M | 17.4M | 12.4M | 11.5M | 149.8K | |
31.6M | 35.1M | 48.3M | 20.2M | 31.1M | 12.2M | 150.3K | |
8.3M | 6.6M | 9M | 4.1M | 3M | 219.7K | 0.0 | |
8.1M | 4M | 5.2M | 1.8M | 1.9M | 23K | 0.0 | |
239.8K | 2.6M | 3.8M | 2.3M | 1.1M | 196.7K | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | 1M | 0.0 | 0.0 | |
0.0 | 1.1M | 1.1M | 835.8K | 0.0 | 121K | 25.4K | |
2.7M | 1.7M | 6.9K | 1.8M | 900.2K | 0.0 | 0.0 | |
42.6M | 44.5M | 58.4M | 26.9M | 36M | 12.5M | 175.6K | |
NON-CURRENT ASSETS | |||||||
41.6K | 82.2K | 86.7K | 107.6K | 2.4M | 46.4K | 3.4K | |
0.0 | 0.0 | 0.0 | 9.1M | 9.1M | 0.0 | 0.0 | |
1M | 1.2M | 1.4M | 6.8M | 9.1M | 0.0 | 0.0 | |
1M | 1.2M | 1.4M | 15.9M | 18.2M | 0.0 | 0.0 | |
0.0 | 0.0 | 487.6K | 0.0 | 0.0 | 0.0 | 0.0 | |
531K | 1.4M | 515.6K | 3.4M | 314.4K | 0.0 | -3.4K | |
1.6M | 2.7M | 2.5M | 19.3M | 20.9M | 46.4K | 3.4K | |
44.1M | 47.2M | 60.9M | 46.3M | 56.8M | 12.6M | 179K | |
LIABILITIES | |||||||
CURRENT LIABILITIES | |||||||
3.8M | 982.7K | 161.6K | 316.1K | 1.1M | 647.6K | 6.4K | |
3.8M | 982.7K | 161.6K | 316.1K | 1.1M | 647.6K | 6.4K | |
0.0 | 2.8M | 1.7M | 1.7M | 2M | 134K | 269.4K | |
0.0 | 6.7M | 10.7K | 0.0 | 13.1K | 0.0 | 184.3K | |
12.1K | 23.4K | 0.0 | 21.6K | 247.3K | 0.0 | 0.0 | |
5.3M | 4.5M | 2.2M | 2.6M | 976.3K | 158.9K | 0.0 | |
5.3M | 1.6M | 2.7M | 3.7M | 2.4M | 346.7K | 0.0 | |
14.4M | 16.6M | 6.8M | 8.4M | 6.8M | 1.3M | 460.1K | |
NON-CURRENT LIABILITIES | |||||||
0.0 | 0.0 | 23M | 25.1M | 24.3M | 0.0 | 0.0 | |
408.4K | 215.9K | 487.6K | 0.0 | 0.0 | 0.0 | 0.0 | |
0.0 | 512.1K | 2.9M | 0.0 | 0.0 | 0.0 | 0.0 | |
408.4K | 728.1K | 26.4M | 25.5M | 24.9M | 0.0 | 0.0 | |
0.0 | -215.9K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
12.1K | 23.4K | 0.0 | 398.2K | 858.8K | 0.0 | 0.0 | |
14.4M | 17.1M | 33.2M | 33.8M | 31.7M | 1.3M | 460.1K | |
SHAREHOLDERS' EQUITY | |||||||
31.1K | 31K | 30.9K | 32.3K | 31.8K | 21.2K | 7.7K | |
82.5M | 79.9M | 73.8M | 71.2M | 58M | 17.5M | 1M | |
-52.8M | -49.9M | -46.1M | -58.8M | -32.8M | -6.3M | -1.3M | |
29.8M | 30.1M | 27.7M | 12.4M | 25.2M | 11.3M | -281K | |
29.8M | 30.1M | 27.7M | 12.4M | 25.2M | 11.3M | -281K | |
SUMMARY | |||||||
44.1M | 47.2M | 60.9M | 46.3M | 56.8M | 12.6M | 179K | |
18.6M | 30.5M | 42.3M | 17.4M | 12.4M | 11.5M | 149.8K | |
12.1K | 6.7M | 23M | 25.5M | 25.1M | 0.0 | 184.3K | |
-12.9M | 2.1M | 17M | 22.7M | 6.5M | -665.5K | 183.8K | |
31,133,134 | 31,133,134 | 31,133,134 | 31,133,134 | 31,133,134 | 31,133,134 | 31,133,134 |
FORA - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 15, 2026 | May 15, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 15, 2026 | March 31, 2026 | 2026 | |
10-K/A 10-K/A 2025 FY (Amended) FY | April 30, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | April 03, 2026 | April 02, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 27, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 27, 2026 | March 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 08, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | December 15, 2025 | January 08, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 14, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 14, 2025 | November 14, 2025 | 2025 |
Continue your FORA research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.